JLab Hear OTC vs Sony CRE-C20

The JLab Hear OTC is a budget-friendly OTC hearing aid priced at $100, earning a B grade with a SoundScore of 3.6/5 in HearAdvisor's lab testing. This visible-in-ear device ranks #36 of 65 OTC hearing aids tested, placing it in the top 54% of its category. In our testing, the JLab Hear OTC shows a distinctive performance profile with clear strengths and weaknesses. Music streaming stands out as exceptional, scoring 4.6/5—a remarkable 2.68 points above the category average. Feedback handling also performs excellently at 5.0/5, providing stable amplification without whistling during our standardized challenge motions. These strengths make it particularly well-suited for users who prioritize streaming audio content. However, speech performance presents limitations. Speech in quiet scores 2.1/5, which is 0.67 points below the category average of 2.79. Speech in noise is more constrained at 1.0/5, falling 0.46 points below average. Own-voice comfort also scores low at 1.8/5, which is 0.71 points below the category norm. These results suggest the device may be less effective for primary speech amplification needs compared to alternatives in its price range. The JLab Hear OTC includes rechargeable batteries and supports both iPhone and Android streaming with hands-free functionality. At this price point, competitors like the Elehear Beyond (4.36/5) and Apple AirPods Pro 2 (4.06/5) offer stronger overall sound performance. This device may appeal most to budget-conscious users who value excellent streaming quality and feedback stability over speech enhancement capabilities.

The Sony CRE-C20 is an invisible-in-ear OTC hearing aid priced at $999, earning a B grade with a SoundScore of 3.6/5 in our lab testing. This mid-priced device offers a discreet form factor with rechargeable batteries, positioning it in the upper tier of the OTC market. In our testing, the CRE-C20 demonstrates notable strengths in speech clarity. Speech in quiet scores 4.1/5—a strong result that sits 1.33 points above the OTC category average. Speech in noise performance reaches 2.7/5, which is 1.24 points above the category average, though only mixed in absolute terms. Own voice comfort scores 2.9/5, slightly above average for the category at +0.39 points. The device shows significant limitations in other areas. Music streaming scored 0.0/5, falling 1.92 points below the category average—this invisible-in-ear design does not support audio streaming functionality. Feedback handling registers at 3.9/5, which is solid in absolute terms, though 0.64 points below the category average of 4.54/5. The CRE-C20 demonstrates meaningful improvement with proper adjustment. The normalized Initial Score of 3.4/5 improves to 4.2/5 when tuned, suggesting users who invest time in optimization will see better results. Within its price range, alternatives like the Sony CRE-E10 (4.69/5) and Lexie B2 Plus (4.43/5) score higher overall. The CRE-C20 is best suited for users prioritizing discretion and speech clarity who don't need music streaming capabilities.